China SXT Pharmaceuticals Inc (SXTC) Stock Analysis

China SXT Pharmaceuticals Inc (SXTC) is a publicly traded company in the HEALTHCARE sector. It trades at $1.74, carries a market capitalization of $7.49M. This page summarizes the public market data, fundamentals, and frequently asked questions for SXTC, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

Market Sentiment

China SXT Pharmaceuticals Inc currently has a Neutral sentiment score of 0.14.

About China SXT Pharmaceuticals Inc

China SXT Pharmaceuticals Inc. is a prominent player in the pharmaceutical industry, specializing in the research, development, manufacture, marketing, and sale of Traditional Chinese Medicine Tablets (TCMP) within China. Headquartered in Taizhou, the company leverages the rich heritage of Chinese medicine to deliver innovative healthcare solutions that cater to the growing demand for natural therapies. With a strong focus on quality and efficacy, China SXT is positioned to capitalize on the ...

GNG Research Analysis

GNG Research scores China SXT Pharmaceuticals Inc (SXTC) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for SXTC.

Frequently Asked Questions

Does SXTC pay dividends?

China SXT Pharmaceuticals Inc (SXTC) does not currently pay a regular dividend.

What is SXTC's market cap?

China SXT Pharmaceuticals Inc (SXTC) has a market capitalization of $7.49M with a current stock price of $1.74.